{
    "id": 2755,
    "fullName": "LTK R669Q",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "LTK R669Q lies within the protein kinase domain of the Ltk protein (UniProt.org). The functional effect of R669Q is conflicting as it results in increased kinase activity in cell based assays and frees epithelial cells from contact inhibition, but does not transform hematopoietic cells (PMID: 22347506), and therefore, its effect on Ltk protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 1347,
                    "pubMedId": 22347506,
                    "title": "ALK-activating homologous mutations in LTK induce cellular transformation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22347506"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4058,
        "geneSymbol": "LTK",
        "terms": [
            "LTK",
            "TYK1"
        ]
    },
    "variant": "R669Q",
    "createDate": "12/17/2014",
    "updateDate": "10/18/2019",
    "referenceTranscriptCoordinates": {
        "id": 151658,
        "transcript": "NM_002344",
        "gDna": "chr15:g.41504984C>T",
        "cDna": "c.2006G>A",
        "protein": "p.R669Q",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1471,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the ALK inhibitor Xalkori (crizotinib) inhibited anchorage independent growth in soft agar of transformed cells harboring LTK R669Q (PMID: 22347506).",
            "molecularProfile": {
                "id": 2572,
                "profileName": "LTK R669Q"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1347,
                    "pubMedId": 22347506,
                    "title": "ALK-activating homologous mutations in LTK induce cellular transformation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22347506"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2572,
            "profileName": "LTK R669Q",
            "profileTreatmentApproaches": [
                {
                    "id": 171,
                    "name": "ALK Inhibitor",
                    "profileName": "LTK R669Q"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 151658,
            "transcript": "NM_002344",
            "gDna": "chr15:g.41504984C>T",
            "cDna": "c.2006G>A",
            "protein": "p.R669Q",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}